SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-18-027105
Filing Date
2018-05-01
Accepted
2018-05-01 16:31:01
Documents
1
Period of Report
2018-04-30

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 12317
  Complete submission text file 0001209191-18-027105.txt   13989
Mailing Address 950 WINTER STREET WALTHAM MA 02451
Business Address 950 WINTER STREET WALTHAM MA 02451 (858) 909-0749
Eloxx Pharmaceuticals, Inc. (Issuer) CIK: 0001035354 (see all company filings)

IRS No.: 841368850 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 8731 Services-Commercial Physical & Biological Research

Mailing Address C/O ARNO THERAPEUTICS, INC. 200 ROUTE 31 NORTH, SUITE 104 FLEMINGTON NJ 08822
Business Address
Kariv Tomer (Reporting) CIK: 0001568077 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-31326 | Film No.: 18795953